Zhenro Properties exchange offer and consent solicitations
The consent solicitations involve notes and perpetual securities
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Yonghe HK$1.49 billion IPO
The shares are listed on the HKEX
CANbridge Pharmaceuticals HK$685 million IPO
We advised CANbridge Pharmaceuticals on its IPO and HKEX listing
MicroTech Medical HK$1.82 billion IPO
We advised MicroTech Medical on its IPO and HKEX listing
Abbisko HK$1.7 billion IPO
We advised Abbisko on its IPO and HKEX listing
Broncus Holding HK$1.55 billion IPO
We advised Broncus on its IPO and HKEX listing
Kindstar Globalgene Technology HK$2.21 billion IPO
We advised Kindstar Global on its IPO and HKEX listing
Zhenro Properties Group RMB1.3 billion green high-yield notes offering
We advised the initial purchasers on the Regulation S offering of senior notes, issued under Zhenro’s green bond framework
Zylox-Tonbridge Medical Technology HK$2.56 billion IPO
We advised Zylox-Tonbridge Medical Technology on its IPO and HKEX listing
HUTCHMED HK$4.17 billion IPO and primary listing
The shares are listed on the Hong Kong Stock Exchange